日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology

阿莫西林可改善代谢功能障碍相关性脂肪性肝炎的肝纤维化:采用常规病理学和数字病理学多模式评估的结果

Ratziu, Vlad; Yilmaz, Yusuf; Lazas, Don; Friedman, Scott L; Lackner, Caroline; Behling, Cynthia; Cummings, Oscar W; Chen, Li; Petitjean, Mathieu; Gilgun-Sherki, Yossi; Gorfine, Tali; Kadosh, Shaul; Eyal, Eli; Sanyal, Arun J

Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study

托吡酯联合塞尼立维罗治疗非酒精性脂肪性肝炎与单药治疗的比较:来自 2b 期 TANDEM 研究的结果

Anstee, Quentin M; Lucas, Kathryn J; Francque, Sven; Abdelmalek, Manal F; Sanyal, Arun J; Ratziu, Vlad; Gadano, Adrian C; Rinella, Mary; Charlton, Michael; Loomba, Rohit; Mena, Edward; Schattenberg, Jörn M; Noureddin, Mazen; Lazas, Donald; Goh, George B B; Sarin, Shiv K; Yilmaz, Yusuf; Martic, Miljen; Stringer, Rowan; Kochuparampil, Jossy; Chen, Li; Rodriguez-Araujo, Gerardo; Chng, Elaine; Naoumov, Nikolai V; Brass, Clifford; Pedrosa, Marcos C